curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles

by palligoelme@gmail.com | Sep 28, 2026 | Clinical Trials

​ Conditions: Obesity (BMI Equal to or >30); Immune Function; HDL; Gut Microbiome; Healthy Adult Participants Interventions: Other: Egg whites; Other: Whole eggs Sponsors: University of Connecticut Recruiting Conditions: Obesity (BMI Equal to or >30); Immune...

Bayesian Optimization of DBS for Gait

by palligoelme@gmail.com | Sep 28, 2026 | Clinical Trials

​ Conditions: Parkinson Disease (PD) Interventions: Other: Deep Brain Stimulation Sponsors: University of Minnesota Recruiting Conditions: Parkinson Disease (PD) Interventions: Other: Deep Brain Stimulation Sponsors: University of Minnesota...

A Novel Multi-functional Artificial Intelligence System on Treatment Efficacy and Implementation in Colonoscopy

by palligoelme@gmail.com | Sep 28, 2026 | Clinical Trials

​ Conditions: Colorectal Cancer (CRC) Screening Interventions: Device: CADe/CADx Sponsors: Chinese University of Hong Kong Not yet recruiting Conditions: Colorectal Cancer (CRC) Screening Interventions: Device: CADe/CADx Sponsors: Chinese University of Hong Kong Not...

Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases: A Pilot Study at the National University of Malaysia

by palligoelme@gmail.com | Sep 27, 2026 | Clinical Trials

​ Conditions: Hypertension (HTN); Diabetes; Dyslipidaemia Interventions: Other: Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCD©) Sponsors: National University of Malaysia; The Malaysian Health Economic Association (MAHEA) Recruiting Conditions:...

Real-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure

by palligoelme@gmail.com | Sep 25, 2026 | Clinical Trials

​ Conditions: Chronic Heart Failure; Coronary Heart Disease (CHD) Interventions: Drug: Yiqi Fumai Lyophilized Injection Sponsors: China Academy of Chinese Medical Sciences Not yet recruiting Conditions: Chronic Heart Failure; Coronary Heart Disease (CHD)...
« Older Entries
Next Entries »

Recent Posts

  • GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
  • Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
  • ABVN Phase 2 – Vagal Maneuvers
  • A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
  • Semaglutide for the Treatment of Cannabis Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®